chr7-152105274-G-A
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate
The NM_022087.4(GALNT11):c.616G>A(p.Val206Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000644 in 1,613,884 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
NM_022087.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GALNT11 | NM_022087.4 | c.616G>A | p.Val206Ile | missense_variant | 5/12 | ENST00000430044.7 | NP_071370.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GALNT11 | ENST00000430044.7 | c.616G>A | p.Val206Ile | missense_variant | 5/12 | 5 | NM_022087.4 | ENSP00000395122.2 | ||
GALNT11 | ENST00000434507.5 | c.616G>A | p.Val206Ile | missense_variant | 7/14 | 2 | ENSP00000416787.1 | |||
GALNT11 | ENST00000447778.5 | n.*90G>A | non_coding_transcript_exon_variant | 4/7 | 5 | ENSP00000395078.1 | ||||
GALNT11 | ENST00000447778.5 | n.*90G>A | 3_prime_UTR_variant | 4/7 | 5 | ENSP00000395078.1 |
Frequencies
GnomAD3 genomes AF: 0.0000526 AC: 8AN: 152176Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000135 AC: 34AN: 251004Hom.: 0 AF XY: 0.000177 AC XY: 24AN XY: 135672
GnomAD4 exome AF: 0.0000657 AC: 96AN: 1461590Hom.: 1 Cov.: 30 AF XY: 0.0000963 AC XY: 70AN XY: 727072
GnomAD4 genome AF: 0.0000525 AC: 8AN: 152294Hom.: 0 Cov.: 33 AF XY: 0.0000940 AC XY: 7AN XY: 74470
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 06, 2023 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at